Immunofluorescent staining confirmed a decrease in both HIF1-a and pimonidazole in the IHM group, implying that generating O2 in the tumour not only improved the efficiency of PDT, but also weakened tumour hypoxia. The gene discussed is SETD2; the disease is neoplasm.